Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Innovent Biologics and MD Anderson Announce a Strategic Collaboration to Develop anti-PD-1 Therapy TYVYT® (Sintilimab Injection) in Rare Cancers
2020-05-19 07:30
Syntekabio Presents Nonclinical Data of immuno-oncologic agent STB-C017 at the 2020 AACR meeting
2020-05-15 12:01
Syntekabio Presents Nonclinical Data of immuno-oncologic agent STB-C017 at the 2020 AACR meeting
2020-05-15 12:01
Duke-NUS, GenScript and A*STAR launch first-in-the-world SARS-CoV-2 serology test to detect neutralising antibodies without need of containment facility or specimen
2020-05-15 11:52
Innovent Announces Key Results from a Number of Clinical Studies to Be Presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting
2020-05-15 07:30
INOVIO's INO-5401 in Combination with PD-1 Inhibitor Libtayo(R) (cemiplimab) Demonstrates 85% of Newly Diagnosed Glioblastoma Patients Are Alive 12 Months Following Treatment
2020-05-14 19:00
SciMount announces FDA approval of SMP-100's IND application for the treatment of Irritable Bowel Syndrome
2020-05-14 18:00
Halodine(R) Nasal and Oral Antiseptics Show Rapid Antiviral Activity Against SARS-CoV-2 (COVID-19)
2020-05-14 09:26
TYVYT® (Sintilimab Injection) ORIENT-2 Study Met its Primary Endpoint of Overall Survival in the Second-Line Treatment of Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma
2020-05-14 07:30
Breakthrough Innovation in Cancer Care From Merck Pipeline to Be Presented at ASCO 2020
2020-05-14 06:46
Hetero Enters Into a Licensing Agreement With Gilead Sciences, Inc. for the Manufacturing and Distribution of "Remdesivir" in 127 Countries, Including India, for COVID-19
2020-05-14 01:56
First Patient Dosed with I-Mab's CD73 Antibody TJD5 in Phase 1/2 Clinical Trial in China for Advanced Solid Tumors
2020-05-13 20:00
Ascletis' THR- beta Agonist ASC41 Receives Approval for Clinical Trials of NASH Indication
2020-05-13 18:30
Cipla Enters Into a Licensing Agreement With Gilead to Expand Access to COVID-19 Treatment
2020-05-13 17:51
ChemPartner Assists the Mount Sinai Health System in Producing Reagent for COVID-19 Research
2020-05-12 23:03
China Biologic Products to Report First Quarter 2020 Financial Results
2020-05-12 20:30
QPS Announces Novel Coronavirus/COVID-19 Testing Capability
2020-05-12 19:11
Merck Granted U.S. Patents for Foundational CRISPR-Cas9 Technology
2020-05-11 21:00
Technopath Clinical Diagnostics Expands Its Portfolio of Third-party Quality Control Solutions for COVID-19 as Clinical Laboratories Globally Ramp Up Antibody Testing
2020-05-11 14:00
Daewoong Pharmaceutical Unveils Phase 3 Clinical Data of Fexuprazan, A Novel Potassium-competitive Acid Blocker
2020-05-11 08:00
1
295
296
297
298
299
412